甘精胰岛素联合瑞格列奈治疗初诊2型糖尿病的疗效观察
黄瑞华
【期刊名称】《中国社区医师》 【年(卷),期】2014(000)011
【摘要】目的：探讨甘精胰岛素联合瑞格列奈治疗初诊2型糖尿病的临床疗效。方法：收治初诊 T2DM 患者40例，经甘精胰岛素联合瑞格列奈治疗16周，比较治疗前后空腹血糖（FBG）、餐后2小时血糖（PBG）、糖化血红蛋白(HbA1C)的差异，同时观察总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、血常规、肝、肾功能的变化及体重指数(BMI)，低血糖的药物不良反应。结果：治疗12周后，与治疗前相比，FBG、PBG、HbA1C均降低(P＜0.05)， TC、TG、LDL-C，血常规、肝、肾功能、BMI与治疗前相比差异无统计学意义(P＞0.05)，有低血糖反应3例次。结论：甘精胰岛素联合瑞格列奈治疗初诊T2DM患者，能使血糖下降明显，且不良反应轻微、安全。%Objective:To investigate the clinical efficacy of insulin glargine combined with repaglinide
in
the
treatment
of
newly
diagnosed
type
2
diabetes.Methods:40 newly diagnosed patients with T2DM were selected,they were treated with insulin glargine combined with repaglinide
for
16
weeks.Fasting
blood
glucose(FBG),2
hour
postprandial blood glucose(PBG),glycosylated hemoglobin(HbA1C) before and after treatment were compared.At the same time,total cholesterol(TC),triglyceride(TG),low routine,liver
density function
lipoprotein(LDL-C),blood and
body
mass
and kidney
index(BMI),hypoglycemia were observed.Results:After 12 weeks of treatment,compared with before treatment,FBG,PBG,HbA1C were decreased(P<0.05);TC,TG,LDL-C,blood
routine,
liver
and
renal
function,BMI compared with before treatment had no significant difference(P<0.05);hypoglycemia occurred in 3 cases.Conclusion:Insulin glargine combined with repaglinide in the treatment of newly diagnosed T2DM patients can make blood sugar decreased obviously,it has minor side effects,and it is safety. 【总页数】2页(34-34,36)
【关键词】甘精胰岛素;瑞格列奈;2型糖尿病 【作者】黄瑞华
【作者单位】221300江苏邳州市人民医院内分泌科 【正文语种】中文 【中图分类】 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_chinese-community-doctors_thesis/0201214823082.html 【相关文献】
1.甘精胰岛素联合阿卡波糖或瑞格列奈治疗老年初诊2型糖尿病的疗效对比观察 [J], 阳玲; 方涛; 黄冠军
2.短期甘精胰岛素联合瑞格列奈门诊治疗初诊2型糖尿病的疗效观察 [J], 刘仕群; 符霞军
3.甘精胰岛素联合瑞格列奈与精蛋白锌重组赖脯胰岛素混合注射液治疗2型糖尿病的疗效与安全性比较 [J], 梁辉; 蒋辉
4.甘精胰岛素联合瑞格列奈治疗初诊2型糖尿病疗效观察 [J], 陈刚; 顾冉 5.甘精胰岛素联合瑞格列奈治疗老年2型糖尿病并早期糖尿病肾病的临床观察 [J], 钟钻仪; 周宇请; 侯淑芳
以上内容为文献基本信息，获取文献全文请下载
甘精胰岛素联合瑞格列奈治疗初诊2型糖尿病的疗效观察
